APOL1 Kidney Disease: A Precision Medicine Approach
Time: 8:30 am
day: Conference Day Two
Details:
- Leveraging genetic insight to identify subpopulations at risk
- Overview of Phase 1 data for APOL1-directed therapy
- Translating genetic insights into precision clinical trial design
